233 related articles for article (PubMed ID: 3729527)
1. Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by use of fluorescein dilaurate test.
Cumming JG; Forsyth JS; Boyd EJ; Frost GJ; Cuschieri A
Arch Dis Child; 1986 Jun; 61(6):573-5. PubMed ID: 3729527
[TBL] [Abstract][Full Text] [Related]
2. Fluorescein dilaurate test of exocrine pancreatic function in cystic fibrosis.
Dalzell AM; Heaf DP
Arch Dis Child; 1990 Jul; 65(7):788-9. PubMed ID: 2386387
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by use of fluorescein dilaurate test.
Puntis J
Arch Dis Child; 1986 Nov; 61(11):1143. PubMed ID: 3789798
[No Abstract] [Full Text] [Related]
4. Spot urine pancreolauryl test for use in infancy.
Green MR; Austin S; McClean P; Jolliffe S; Weaver LT
Arch Dis Child; 1995 Mar; 72(3):233-4. PubMed ID: 7741571
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid.
Nousia-Arvanitakis S; Arvanitakis C; Desai N; Greenberger NJ
J Pediatr; 1978 May; 92(5):734-7. PubMed ID: 305953
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of pancreatic function. Simplified screening with fluorescein dilaurate using serum concentration determinations].
Laggner A; Bastian L; Prager J; Pointner H; Deutsch E
Fortschr Med; 1981 Apr; 99(16):589-91. PubMed ID: 7227951
[TBL] [Abstract][Full Text] [Related]
7. The assay of chymotrypsin in stool as a simple and effective test of exocrine pancreatic activity in cystic fibrosis.
Girella E; Faggionato P; Benetazzo D; Mastella G
Pancreas; 1988; 3(3):254-62. PubMed ID: 3387419
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of pancreatic insufficiency with fluorescein dilaurate in patients with cystic fibrosis (author's transl)].
Schönberger W; Weitzel D
Monatsschr Kinderheilkd (1902); 1980 Apr; 128(4):195-8. PubMed ID: 7366590
[TBL] [Abstract][Full Text] [Related]
9. Faecal chymotrypsin: a reliable index of exocrine pancreatic function.
Brown GA; Sule D; Williams J; Puntis JW; Booth IW; McNeish AS
Arch Dis Child; 1988 Jul; 63(7):785-9. PubMed ID: 3415294
[TBL] [Abstract][Full Text] [Related]
10. Faecal elastase 1 in children with cystic fibrosis.
Gullo L; Graziano L; Babbini S; Battistini A; Lazzari R; Pezzilli R
Eur J Pediatr; 1997 Oct; 156(10):770-2. PubMed ID: 9365065
[TBL] [Abstract][Full Text] [Related]
11. Dual marker one day pancreolauryl test.
Green MR; Austin S; Weaver LT
Arch Dis Child; 1993 May; 68(5):649-52. PubMed ID: 8323334
[TBL] [Abstract][Full Text] [Related]
12. Fecal chymotrypsin: a new diagnostic test for exocrine pancreatic insufficiency in children with cystic fibrosis.
Scotta MS; Marzani MD; Maggiore G; De Giacomo C; Melzi D'Eril GV; Moratti R
Clin Biochem; 1985 Aug; 18(4):233-4. PubMed ID: 4042320
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity assessment of chymotrypsin faecal test in controlling malabsorption in cystic fibrosis.
Santini B; Lerro P; Ciervo T; Robazza PV; Ansaldi N
Acta Univ Carol Med (Praha); 1990; 36(1-4):165-8. PubMed ID: 2130685
[No Abstract] [Full Text] [Related]
14. Secretin-stimulated ultrasound estimation of pancreatic secretion in cystic fibrosis validated by magnetic resonance imaging.
Engjom T; Tjora E; Wathle G; Erchinger F; Lærum BN; Gilja OH; Haldorsen IS; Dimcevski G
Eur Radiol; 2018 Apr; 28(4):1495-1503. PubMed ID: 29134356
[TBL] [Abstract][Full Text] [Related]
15. Detection and follow up of exocrine pancreatic insufficiency in cystic fibrosis: a review.
Leus J; Van Biervliet S; Robberecht E
Eur J Pediatr; 2000 Aug; 159(8):563-8. PubMed ID: 10968231
[TBL] [Abstract][Full Text] [Related]
16. Serum PABA and fluorescein in the course of Bz-Ty-PABA and pancreolauryl test as an index of exocrine pancreatic insufficiency.
Cavallini G; Piubello W; Brocco G; Micciolo R; Chech G; Angelini G; Benini L; Riela A; Dalle Molle L; Vantini I
Dig Dis Sci; 1985 Jul; 30(7):655-63. PubMed ID: 3874051
[TBL] [Abstract][Full Text] [Related]
17. Fecal elastase-1 cut-off levels in the assessment of exocrine pancreatic function in cystic fibrosis.
Walkowiak J; Nousia-Arvanitakis S; Cade A; Kashirskaya N; Piotrowski R; Strzykala K; Kouniou M; Pogorzelski A; Sands D; Kapranov N
J Cyst Fibros; 2002 Dec; 1(4):260-4. PubMed ID: 15463824
[TBL] [Abstract][Full Text] [Related]
18. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
Dorlöchter L; Aksnes L; Fluge G
Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and therapeutic applications of bentiromide screening test for exocrine pancreatic insufficiency in patients with cystic fibrosis. Comparison with other tests of exocrine pancreatic disease.
Hubbard VS; Wolf RO; Lester LA; Egge AC
Dig Dis Sci; 1984 Oct; 29(10):881-9. PubMed ID: 6206989
[TBL] [Abstract][Full Text] [Related]
20. Pancreolauryl and NBT-PABA tests. Are serum tests more practicable alternatives to urine tests in the diagnosis of exocrine pancreatic insufficiency?
Lankisch PG; Brauneis J; Otto J; Göke B
Gastroenterology; 1986 Feb; 90(2):350-4. PubMed ID: 3484456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
